rs797045655
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_001244008.2(KIF1A):c.821C>T(p.Ser274Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001244008.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 30 Pathogenic:4
Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as Pathogenic. Following criteria are met: 0103 - Both loss- and gain-of-function are known mechanisms of disease for this gene. Both loss and gain of function mechanisms have been reported for variants causing spastic paraplesia (PMID: 31488895, PMID: 31455732). However neuropathy has been reported to be caused by loss of function variants only (PMID: 22258533). (N) 0104 - Dominant negative is a mechanism of disease for this gene. Missense clustering within the kinesin domain have been shown to cause NESCAV syndrome due to a dominant negative disease mechanism (PMID: 28970574). (N) 0108 - This gene is known to be associated with both recessive and dominant disease. Missense variants and variants resulting in a premature termination codon have been reported to cause dominant and recessive disease. Missense variants found within the kinesin domain are likely to cause a dominant form of disease (PMID: 31488895, PMID: 31455732, PMID: 28970574). (N) 0200 - Variant is predicted to result in a missense amino acid change from serine to leucine (exon 9). (N) 0251 - Variant is heterozygous. (N) 0301 - Variant is absent from gnomAD. (P) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (P) 0603 - Missense variant in a region that is highly intolerant to missense variation (high constraint region) (kinesin domain; PDB, NCBI). (P) 0705 - No comparable variants have previous evidence for pathogenicity. (N) 0802 - Moderate previous evidence of pathogenicity in unrelated individuals. This variant has been report once as de novo in an individual with intellectual disability, and in another individual with a KIF1A-related condition (ClinVar, LOVD). It has also been reported in a severely affected individual with a dominant condition, however the exact phenotype of this individual is unclear (Conference poster; Boyle, (2019)). (P) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant. (N) 1204 - Variant shown to be de novo in proband (parental status not tested but assumed). (P) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign -
- -
Variant confirmed as disease-causing by referring clinical team -
- -
not provided Pathogenic:2
Published functional studies demonstrate impaired microtubule binding (Boyle L et al., 2021); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33880452, 26125038, 21376300, 21820098) -
- -
Hereditary spastic paraplegia Pathogenic:1
This missense variant results in a change from serine to tryptophan at amino acid position 274. It has been previously reported in individuals with KIF1A-related disorders (PMID: 33880452). Functional studies support that this variant impairs kinesin motor activity (PMID: 33880452). This variant has not been observed in population controls of the Genome Aggregation Database (gnomAD). In silico prediction programs predict this variant to impact protein function. Based on the evidence above, this variant is classified as pathogenic (PS3, PS2, PS4_M, PM2, PM1, PP3, PP5). -
Intellectual disability, autosomal dominant 9 Pathogenic:1
- -
Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Pathogenic:1
This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 274 of the KIF1A protein (p.Ser274Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of autosomal dominant KIF1A-related conditions (PMID: 33880452; Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 211298). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KIF1A protein function. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at